Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells

Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105380/
https://www.ncbi.nlm.nih.gov/pubmed/33963242
http://dx.doi.org/10.1038/s42003-021-02092-3
_version_ 1783689599383502848
collection PubMed
description Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer research labs based on the Netherlands. In this short Q&A, she tells us about her research and how her diverse background has helped her as a scientist. Dr. Akkari also shares some great pointers on the biggest hurdles women in STEM face and tips to overcome them.
format Online
Article
Text
id pubmed-8105380
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81053802021-05-11 Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells Commun Biol Q&A Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer research labs based on the Netherlands. In this short Q&A, she tells us about her research and how her diverse background has helped her as a scientist. Dr. Akkari also shares some great pointers on the biggest hurdles women in STEM face and tips to overcome them. Nature Publishing Group UK 2021-05-07 /pmc/articles/PMC8105380/ /pubmed/33963242 http://dx.doi.org/10.1038/s42003-021-02092-3 Text en © Springer Nature Limited 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Q&A
Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_full Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_fullStr Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_full_unstemmed Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_short Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
title_sort targeting the undruggable: an interview with leila akkari on fighting cancer by rewiring cells
topic Q&A
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105380/
https://www.ncbi.nlm.nih.gov/pubmed/33963242
http://dx.doi.org/10.1038/s42003-021-02092-3

Ejemplares similares